Concepedia

Jana Marková

JM

Statistics

Publications

53

Citations

3.8K

H-Index

24

Active since

1998

Affiliations

University Hospital Kralovske Vinohrady(Current)

Charles University

University Hospital Cologne

University of Cologne

University of Tübingen

Jana Marková is an author at University Hospital Kralovske Vinohrady specializing in medicine, oncology, and hodgkin lymphoma therapy.

ORCID

Publications per year

1998–2023

53

Publications

53

Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial

Andreas Engert, Heinz Haverkamp, Carsten Kobe et al. · The Lancet · 2012 · 632 citations

, , +15

Intensified Chemotherapy and Dose-Reduced Involved-Field Radiotherapy in Patients With Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD11 Trial

Hans Theodor Eich, Volker Diehl, Helen Görgen et al. · Journal of Clinical Oncology · 2010 · 436 citations · Full text

, , +16

PET-guided treatment in patients with advanced-stage Hodgkin's lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group

Peter Borchmann, Helen Goergen, Carsten Kobe et al. · The Lancet · 2017 · 386 citations

, , +12

Dose-Intensification in Early Unfavorable Hodgkin's Lymphoma: Final Analysis of the German Hodgkin Study Group HD14 Trial

Bastian von Tresckow, Annette Plütschow, Michael Fuchs et al. · Journal of Clinical Oncology · 2012 · 314 citations · Full text

, , +11

Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphoma

Carsten Kobe, Markus Dietlein, Jeremy Franklin et al. · Blood · 2008 · 204 citations · Full text

, , +17

1–5 of 53